BRIGHT BIOTECH LIMITED

Active Manchester

Research and experimental development on biotechnology

8 employees website.com
Life sciences and medical technology Research and experimental development on biotechnology
B

BRIGHT BIOTECH LIMITED

Research and experimental development on biotechnology

Founded 10 Oct 2019 Active Manchester, England 8 employees website.com
Life sciences and medical technology Research and experimental development on biotechnology
Accounts Submitted 23 Sept 2025 Next due 30 Sept 2026 3 months remaining
Confirmation Submitted 3 Oct 2025 Next due 4 Oct 2026 3 months remaining
Net assets £881K £643K 2024 year on year
Total assets £903K £653K 2024 year on year
Total Liabilities £21K £9K 2024 year on year
Charges None No charges registered

Contact & Details

Contact

Registered Address

Rutherford House Unit 16 Pencroft Way Manchester Science Park Manchester M15 6SZ England

Email

info@example.com

Website

www.example.com

Full company profile for BRIGHT BIOTECH LIMITED (12253910), an active life sciences and medical technology company based in Manchester, England. Incorporated 10 Oct 2019. Research and experimental development on biotechnology. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2024
Type total-exemption-full
Next accounts 31 Dec 2025
Due by 30 Sept 2026 3 months remaining

Net Assets, Total Assets & Total Liabilities (2020–2024)

Cash in Bank

£667.12k

Decreased by £626.20k (-48%)

Net Assets

£881.15k

Decreased by £643.43k (-42%)

Total Liabilities

£21.44k

Decreased by £9.42k (-31%)

Turnover

N/A

Employees

8

Increased by 6 (+300%)

Debt Ratio

2%

Financial History

Revenue, profit, EBITDA and key financial figures

2024
31 Dec Year End
2023
31 Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

Funding Rounds 1

Investors (5)

Investor NameInvestor SinceParticipating Rounds
Investor 1Nov 2022Seed
Investor 2Nov 2022Seed
Investor 3Nov 2022Seed

Share Capital

Share Capital

Share allotments and capital structure

4 Allotments 63,276 Shares £2.65m Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
17 Apr 20257,470£404k£54.09
14 Sept 202243,469£2.16m£49.658
14 Sept 20223,672£91k£24.712
14 Sept 20228,665£0£0

Officers

Officers

2 active 1 resigned
Status
Mohammad El HajjDirectorLebaneseEngland3610 Oct 2019Active
Mohammad Farid KhanDirectorBritishEngland553 Oct 2022Active

Shareholders

Shareholders (12)

Bright Biotech - Treasury
19.9%
32,570
Mohammad El Hajj
19.9%
32,570

Persons with Significant Control

Persons with Significant Control (0)

0 Active 2 Ceased

Mohammad El Hajj

Ceased 14 Sept 2022

Ceased

Tariq Ali

Ceased 14 Sept 2022

Ceased

Group Structure

Group Structure

No group structure identified

Charges

Charges

No charges registered

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
3 Oct 2025OfficersChange to director Dr Mohammad El Hajj on 19 Sept 2025
3 Oct 2025OfficersChange to director Dr. Mohammad Farid Khan on 19 Sept 2025
3 Oct 2025Confirmation StatementConfirmation statement made on 20 Sept 2025 with updates
23 Sept 2025AccountsAnnual accounts made up to 31 Dec 2024
2 May 2025OfficersTermination of Nicolaus Norden as director on 30 Apr 2025
3 Oct 2025 Officers

Change to director Dr Mohammad El Hajj on 19 Sept 2025

3 Oct 2025 Officers

Change to director Dr. Mohammad Farid Khan on 19 Sept 2025

3 Oct 2025 Confirmation Statement

Confirmation statement made on 20 Sept 2025 with updates

23 Sept 2025 Accounts

Annual accounts made up to 31 Dec 2024

2 May 2025 Officers

Termination of Nicolaus Norden as director on 30 Apr 2025

Recent Activity

Latest Activity

Change to director Dr Mohammad El Hajj on 19 Sept 2025

8 months ago on 3 Oct 2025

Change to director Dr. Mohammad Farid Khan on 19 Sept 2025

8 months ago on 3 Oct 2025

Confirmation statement made on 20 Sept 2025 with updates

8 months ago on 3 Oct 2025

Annual accounts made up to 31 Dec 2024

8 months ago on 23 Sept 2025

Termination of Nicolaus Norden as director on 30 Apr 2025

1 years ago on 2 May 2025